People with ADHD might be prescribed their meds remotely without increasing their risk of addiction, a new study says. Experts have worried that prescribing stimulants like Adderall through telehealth visits might increase substance abuse among people with attention-deficit/hyperactivity disorder (ADHD). But this study found no increased risk among ADHD patients prescribed their meds via telehealth versus those who got their scrips at an in-person visit, according to results published June 11 in the American Journal of Psychiatry. “Our study suggests that, generally, telehealth-based relationships – which make health care more accessible – can be safe and don’t increase the risk of substance use disorder,” lead researcher Dr. Vinod Rao, medical director of adult ambulatory psychiatry at Massachusetts General Hospital in Boston, said in a news release. For the study, researchers tracked nearly 8,000 patients treated for ADHD at Massachusetts General Hospital between March 2020 and August 2023, a time during which many doctors pivoted to telehealth due to the COVID-19 pandemic. About 46% of the patients had an in-person appointment on the day their first stimulant was prescribed, results show. Overall, about 91% of patients had at least one in-person visit with their doctor prior to their first prescription, while 9% had a telehealth-only relationship with their doc. Patients who never met their doc in person were not more likely to develop a substance use… read on > read on >







